Tiny trial tests injection for rare eye disease in boys
NCT ID NCT06066008
First seen Apr 29, 2026 · Last updated May 13, 2026 · Updated 5 times
Summary
This very early study tested a new medicine called ZM-01 in just 2 boys aged 3-18 with X-linked retinoschisis, a rare genetic eye condition that causes vision loss. The medicine was injected into one eye to check for safety and any improvement in sight. The main goal was to see if the treatment caused any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for X-LINKED RETINOSCHISIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Wuhan University Renmin Hospital affiliated with Hanchuan Hospital
Xiaogan, Hubei, China
Conditions
Explore the condition pages connected to this study.